.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The manufacturing of modern biopharmaceuticals is evolving rapidly. Monoclonal antibody purification has emerged as a cornerstone in producing safe and effective treatments for cancer and autoimmune diseases. Multimodal chromatography (MMC) provides a powerful alternative to traditional methods. It integrates multiple interactions like hydrogen bonding and hydrophobic forces. Consequently, this technology significantly improves the selectivity of the purification process.
Recent studies emphasize the importance of resin selection in bioprocessing. This review compares all commercially available MMC resins. It analyzes performance metrics such as binding capacity and recovery rates. Furthermore, it evaluates the clearance of host cell proteins and DNA. These factors are crucial for maintaining the safety profile of mAb-based products. Therefore, manufacturers are adopting these advanced techniques to streamline production.
In addition to empirical data, the research incorporates molecular-level insights. Techniques such as NMR and molecular docking reveal how antibodies interact with chromatography ligands. This mechanistic understanding allows for a more rational selection of resins. Moreover, high-throughput screening and in silico modeling are now essential enablers. They help predict partition coefficients and optimize mobile phase modifiers.
As a result, these advances support the development of next-generation biopharmaceutical platforms. They ensure that complex molecules like bispecific antibodies and drug conjugates meet strict regulatory standards. Ultimately, improved efficiency in production may lead to better access to affordable biologics in India.
MMC offers higher selectivity compared to traditional ion-exchange or hydrophobic interaction chromatography. It combines multiple binding mechanisms, which allows for better removal of impurities like protein aggregates and host cell contaminants.
By achieving superior clearance of host cell proteins and DNA, MMC reduces the risk of immunogenic reactions in patients. This ensures that the final antibody product is of the highest therapeutic quality and meets rigorous safety standards.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or professional biopharmaceutical consulting. Refer to the latest local and national guidelines for clinical practice.
References
1. Javidanbardan A et al. Multimodal Chromatography in the Downstream Processing of mAb-Based Products: Mechanisms, Strategies, and Applications. Biotechnol Bioeng. 2026 Feb 25. doi: 10.1002/bit.70171. PMID: 41738359.
2. Shukla AA, et al. Downstream processing of monoclonal antibodies--application of platform approaches. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Mar 15;848(1):28-39.
3. Halan V, et al. Multimodal Chromatography for Purification of Biotherapeutics - A Review. Curr Protein Pept Sci. 2019;20(1):4-13.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A comprehensive review of multimodal chromatography in mAb production, focusing on mechanisms, resin selection, and its impact on biopharmaceutical purity....
7 months ago
As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today
Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
